Xelix

Xelix is an AI-native accounts payable platform that bolts onto a company's existing ERP and AP systems rather than replacing them, adding controls, automation and cost recovery on top. It is organised into modules covering invoice capture (Capture), duplicate-payment and fraud detection (Transactions), supplier statement reconciliation (Statements), vendor query management (Helpdesk), master vendor data cleansing (Vendors), and self-serve AP reporting (Reports/Insight). Customers include large enterprises such as Kraft Heinz, GSK, General Electric, Merck, AstraZeneca, UPMC and BAT.

The platform ingests daily invoice, workflow and master-vendor data files (typically via SFTP) from the customer's ERP, plus optional email and SSO integration, so it does not require heavy IT involvement to deploy. Xelix reports processing 220M+ invoices annually across its customer base and being used by teams to prevent duplicate and erroneous payments, reconcile supplier statements at scale, and cut manual AP audit and query-handling effort. Named case studies report results such as $11.8M in prevented duplicate payments at Saint Luke's Health System, 33x more statements reconciled at Liberty Global, and $15M in overpayments prevented in year one at Equans.

Xelix is privately held, headquartered in London with a second office in Wilmington, Delaware, and raised a $160M Series B led by Insight Partners in July 2025, following a 2023 Series A led by FINTOP Capital. It reports 200+ global customers, a 98% customer retention rate, and SOC 2 Type II and ISO 27001 certification.